A wide-reaching executive order was signed by US President Trump, directing drugmakers to lower the prices of their medicines and price it on par with other developed nations. Analysts and legal experts were skeptical about its implementation.
Suscribirse a:
Enviar comentarios (Atom)
Comentarios
Publicar un comentario
Leave a comment. Thanks!
Comentarios de Facebook